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Background: Rescue percutaneous coronary intervention (PCI) reduces death, re-infarction, stroke and heart failure six months post-myocardial 
infarction compared to medical therapy. We investigated the short- and long-term clinical outcomes between ST-elevation myocardial infarction 
(STEMI) patients treated with rescue PCI or primary PCI (PPCI) in a large multicentre Australian PCI registry.
Methods: We analyzed data from 1803 consecutive STEMI patients with 12-month follow-up treated with PCI from April 2004 to October 2007; 
162 (9%) were rescue PCIs.
Results: Significant baseline differences between the rescue PCI and PPCI groups included age (60.4 vs. 62.9, p=0.02), current smoking status 
(45.0% vs. 35.0%, p=0.01), ejection fraction (46.6% vs. 49.5%, p=0.03), STEMI-to-balloon-time (7.9 vs. 4.6 hours, [and door-to-balloon-time] both 
p<0.001), and Killip class IV (9.9% vs. 5.2%, p=0.02). Peri-procedural glycoprotein IIb/IIIa-inhibitor use was less in rescue patients (48.8% vs. 
74.9%, p<0.001), but use of anti-thrombins or clopidogrel preloading was similar. The incidence of pre-PCI Thrombolysis in Myocardial Infarction 
(TIMI) 3 flow was higher among rescue (42.6% vs. 19.5%, p<0.0001) than PPCI patients, however, post-PCI TIMI 3 flow was similar in the two groups 
(89.1% vs. 91.5%, p=0.27). No significant differences were observed in any of the short- or long-term clinical endpoints between rescue PCIs and 
PPCIs including in-hospital bleeding complications (4.9% vs. 3.5%, p=0.34), 30-day mortality (6.2% vs. 6.0%, p=0.94), and overall major adverse 
cardiovascular events (MACE) (11.7% vs. 10.1%, p=0.52), and 12-month mortality (9.0% vs. 8.0%, p=0.67), and MACE (18.0% vs. 18.1%, p=0.99).
Conclusions: Despite a significantly longer ischaemia (STEMI-to-balloon) time and more Killip class IV patients, both short- and long-term clinical 
outcomes were comparable in patients treated with rescue PCI or PPCI for STEMI. This study underscores the critical need to urgently transfer all 
patients to cardiac catheterization laboratory who clinically fail to reperfuse post fibrinolysis.
